GRI

[Press release] Ministry of Food and Drug Safety to hold ‘2024 Second Half Pharmaceutical Review Briefing Session’

News Healthcare & Pharma General Updates
Date: 20th Nov, 2024 Source: Korea Food and Drug Administration (KFDA) Country: South Korea Original Source

Brief

"On 20/11/2024, the Korea Food and Drug Administration (KFDA) issued an update regarding '[Press release] Ministry of Food and Drug Safety to hold ‘2024 Second Half Pharmaceutical Review Briefing Session’". The briefing session aims to enhance understanding of pharmaceutical review among industry stakeholders and support the development of safe and effective pharmaceuticals.

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Food and Drug Administration (KFDA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
Related Documents
Thousands of sick and disabled people to get life-changing support into work
Date: 4th Sep, 2025 Source: Department for Work and Pensions Country: United Kingdom
News Employment & labor General Updates
Financial authorities, MG Insurance Insurance Agreement is transferred to non -reporting (bridge insurance company)
Date: 3rd Sep, 2025 Source: Financial Services Commission Country: South Korea
News Corporate Finance & M&A General Updates
BYD exports Thai -made electric vehicles to Europe
Date: 3rd Sep, 2025 Source: Ministry of Trade (Ticaret Bakanlığı) Country: Turkey
News Consumer protection General Updates

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales